Get access

Novel Lrrk2-p.S1761R mutation is not a common cause of Parkinson's disease in Spain

Authors

  • Ignacio F. Mata PhD,

    Corresponding author
    1. Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA
    2. Department of Neurology, University of Washington School of Medicine, Seattle, Washington, USA
    • Correspondence to: Dr. Ignacio F. Mata, Geriatric Research Education and Clinical Center S-182, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, USA; nachofm@u.washington.edumailto

    Search for more papers by this author
  • Victoria Alvarez PhD,

    1. Laboratorio de Genetica Molecular, Instituto de Investigacion Nefrologica, Hospital Universitario Central de Asturias, Oviedo, Spain
    Search for more papers by this author
  • Renee Ribacoba MD,

    1. Department of Neurology, Hospital Universitario Central de Asturias, Oviedo, Spain
    Search for more papers by this author
  • Jon Infante MD,

    1. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Barcelona, Spain
    2. Department of Neurology, “Marques de Valdecilla” University Hospital, Santander, Spain
    Search for more papers by this author
  • María Sierra MD,

    1. Department of Neurology, “Marques de Valdecilla” University Hospital, Santander, Spain
    Search for more papers by this author
  • Pilar Gómez-Garre PhD,

    1. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Barcelona, Spain
    2. Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
    Search for more papers by this author
  • Pablo Mir MD, PhD,

    1. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Barcelona, Spain
    2. Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
    Search for more papers by this author
  • Sarah Waldherr BS,

    Latin American Research Consortium on the Genetics of Parkinson's Disease
    1. Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA
    Search for more papers by this author
  • Dora Yearout BS,

    1. Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA
    Search for more papers by this author
  • Cyrus P. Zabetian MD, MS

    1. Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA
    2. Department of Neurology, University of Washington School of Medicine, Seattle, Washington, USA
    Search for more papers by this author

  • Funding agencies: This work was supported by grants from the Parkinson's disease Foundation; Department of Veterans Affairs (1I01BX000531), National Institutes of Health (P50 NS062684, R01 NS065070 and R25 TW009345), Fondo de Investigacion Sanitaria (FIS, PI11/00228, PFIS, FI 11/00259, IFIMAV, and WLA 04/11), Instituto de Salud Carlos III (PI11/00093 and PI08/0915), Spanish Ministry of Economy and Competitiveness, European Social Fund, and the Asociación Parkinson Asturias.

  • Membership list of the Latin American Research Consortium on the Genetics of Parkinson's Disease is provided in the Supporting Information.

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Get access to the full text of this article

Ancillary